The importance of radiotherapy of primary tumor in synchronous metastatic disease
01/2020 Special Edition
Doc. MUDr. Renata Soumarová, Ph.D.; MUDr. Tomáš Blažek; MUDr. Marián Liberko
Radioterapeutická a onkologická klinika, 3. LF UK a FN Královské Vinohrady, Praha
Radiotherapy has an important role in treatment of malignant tumors. It is usually used in treatment of localized disease in combination with surgery or as a curative treatment with or without chemotherapy. In metastatic setting, radiotherapy has palliative intent with the aim to relief from suffering. Nevertheless, with improvements in radiotherapy techniques there are also new indications for radiotherapy. Curative radiotherapy doses and techniques are used in metastatic setting with the aim to improve not only local control but also overall survival. Preclinical and experimental studies prove systemic treatment effect of radiotherapy, which leads to immune reactions also outside of irradiated target volume. Combination of radiotherapy with immunotherapy represents new treatment option. The aim of this review is to provide summary of studies, which studies added effect of radiotherapy of primary tumor in synchronous metastatic disease.
radiotherapy, oligometastatic disease, synchronous metastasis, stereotactic radiotherapy, abscopal effect, immunotherapy
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...